# OnCo record carmustine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/carmustine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "carmustine" ;
  schema:name "Carmustine"@en ;
  schema:alternateName "BCNU"@en, "Carmustine implant"@en, "BiCNU / Gliadel Wafer" ;
  schema:description "Carmustine is a chemotherapy that reaches the brain. It is given by infusion for brain tumours, lymphoma and myeloma, and as a slow-release wafer left in the cavity after a brain tumour is removed."@en ;
  schema:url <https://onco.cc/drugs/carmustine/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Carmustine> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=carmustine>, <https://www.cancer.gov/about-cancer/treatment/drugs/carmustine>, <https://www.cancer.gov/about-cancer/treatment/drugs/carmustineimplant> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Alkylating agent (nitrosourea); intravenous and implantable wafer" ;
  onco:approval "US 1977: Brain tumours, multiple myeloma, relapsed Hodgkin and non-Hodgkin lymphoma (BiCNU)", "US 1996: Recurrent glioblastoma as an adjunct to surgery (Gliadel Wafer); newly diagnosed high-grade glioma with surgery and radiation added 2003" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:trials <https://onco.cc/trials/nct06915246/> .